Metropolitan Bank Holding
MCB · NYSE
About MCB
- Employees
- 326
- Headquarters
- New York City, New York
- Listed
- Nov 8, 2017
- Sector
- Financials
- Industry
- Banks
- Website
- investors.mcbankny.com
MCB key statistics
- Market cap
- 1.10B
- Price-earnings ratio
- 11.01
- Dividend yield
- 0.78%
- Average volume
- 124.82K
- Volume
- 205.83K
- Open price
- $87.58
- High today
- $89.33
- Low today
- $87.09
- 52 Week high
- $102.04
- 52 Week low
- $64.66
Metropolitan Bank Holding (MCB) at a glance
As of Oct 20, 2026, Metropolitan Bank Holding (MCB) shares are priced at $88.87, giving the company a market cap of 1.10B, a price-to-earnings ratio of 11.01 and a dividend yield of 0.78%.
Today the stock has traded between $87.09 and $89.33. The current price is 2.0% above the day's low and 0.5% below its high.
Volume so far is 205.83K shares, above the average of 124.82K shares a day.
Over the past year Metropolitan Bank Holding has ranged from $64.66 to $102.04, and now sits 65% of the way up that range.
Metropolitan Bank Holding met or beat analyst EPS estimates in 6 of the last 8 quarters. In Q3 FY26 it reported $2.58 per share against an estimate of $2.36.
The average analyst price target is $108.12, 21.7% above the current price, from 3 recent ratings.
Analyst ratings
Latest rating from each analyst over the past 12 months
- Buy66.7%
- Hold33.3%
- Sell0.0%
- Low
- $101.00
- Now
- $88.87
- High
- $115.50
MCB earnings
Earnings per share, reported against the analyst estimate
Beat the estimate in 6 of the last 8 quarters, by 18.3% on average.
- Q4 FY24: reported $1.88 per share against an estimate of $1.43
- Q1 FY25: reported $1.45 per share against an estimate of $1.36
- Q2 FY25: reported $1.76 per share against an estimate of $1.67
- Q3 FY25: reported $0.67 per share against an estimate of $1.93
- Q4 FY25: reported $2.77 per share against an estimate of $2.09
- Q1 FY26: reported $2.92 per share against an estimate of $2.33
- Q2 FY26: reported $1.54 per share against an estimate of $2.28
- Q3 FY26: reported $2.58 per share against an estimate of $2.36
MCB news
- Press releaseBusiness Wire
- Press releaseBusiness Wire
Metropolitan Bank Holding Corp. Declares Increased Quarterly Common Stock Cash Dividend
- Press releaseBusiness Wire
Metropolitan Bank Holding Corp. Schedules Third Quarter 2026 Earnings Release and Conference Call Dates
- Press releasePRNewswire
MCB Alert: HAGENS BERMAN, NATIONAL TRIAL ATTORNEYS, Encourages Metropolitan Bank Holding Corp. (NYSE: MCB) Investors with Significant Losses to Contact Firm
- Press releaseBusiness Wire
Metropolitan Commercial Bank Receives 2026 WebAward for Outstanding Website Excellence
- Press releasePRNewswire
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Metropolitan Bank Holding Corp.- MCB
- Press releasePRNewswire
MCB Alert: HAGENS BERMAN, NATIONAL TRIAL ATTORNEYS, Encourages Metropolitan Bank Holding Corp. (NYSE: MCB) Investors with Significant Losses to Contact Firm
- Press releaseGlobe Newswire
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Metropolitan Bank Holding Corp. - MCB
Similar companies
Companies in the same industry as Metropolitan Bank Holding
- PFBCPreferred Bank (Los Angeles, CA)$105.09+1.45%
- FMBLFarmers & Merchants Bank Of Long Beach$9,750.00+0.53%
- UVSPUnivest Financial$41.83+1.97%
- HFWAHeritage Financial$27.85+1.42%
- AMTBAmerant Bancorp$29.06+1.96%
- NBNNortheast Bank$127.43+2.15%
- FSBCFive Star Bancorp$43.24+1.29%
- FBAKFirst National Bank Alaska$328.80+0.55%
Most active stocks
Highest trading volume today
- EARIEntertainment Arts Research$0.0003−16.67%
- SEIISharing Economy International$0.0004+100.00%
- NWGLCL Workshop Group$0.1522+27.90%
- TMSHTrans Global Assets$0.0002+0.00%
- AEFIAmerican EcoFuels$0.0007+0.00%
- CBDW1606$0.0002+0.00%
- FITYFifty 1 Labs$0.0001−66.67%
- PRSOPeraso$0.5914+54.13%
- SDSTStardust Power$0.02−23.66%
- SHFSSHF Holdings$0.0899−4.36%
- FRTTFort Technology$0.7121+32.63%
- CBDLCBD Life Sciences$0.0002−25.00%
Newly listed
Companies that went public in the past six weeks
- TCXBTCGX Acquisition Corp. II$10.56+1.54%
- CTYCITY THERAPEUTICS$20.83−2.94%
- IAMIambic Therapeutics$16.01−2.02%
- AMROAmaero$5.68+1.25%
- FLSCFrazier Life Sciences Acquisition Corp. II$10.28−0.10%
- TRXBTRex Bio$14.44−2.43%
- RTSNRetension Pharmaceuticals$16.18−0.92%
- PAXGUPine Tree Acquisition$9.98+0.00%
- PORTUSouthport Acquisition Corp. IIListed Oct 1, 2026
- CHWMChilwa Minerals$5.18+3.39%
- ACCVAccelevation Holdings$12.31−1.44%
- RZAIROZE AI$10.28+1.28%
Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.